Inhibrx Biosciences, Inc.

Inhibrx Biosciences, Inc. At Inhibrx, our mission is to deliver optimized, biologic therapeutics to people with life-threatening conditions.

Ewing sarcoma is a rare and complex cancer that can present significant challenges for the people and families affected ...
09/02/2026

Ewing sarcoma is a rare and complex cancer that can present significant challenges for the people and families affected by the disease.

Continued research is an important part of building a greater understanding of Ewing sarcoma and addressing the unmet needs that remain across the patient journey.

Inhibrx continues to advance research in Ewing sarcoma through our work with ozekibart (INBRX-109).

Learn more about our ongoing research: https://tinyurl.com/6w46a4hm

Ozekibart (INBRX-109) continues to be evaluated in an ongoing Phase 1/2 study that includes cohorts in Ewing sarcoma and...
08/15/2026

Ozekibart (INBRX-109) continues to be evaluated in an ongoing Phase 1/2 study that includes cohorts in Ewing sarcoma and colorectal adenocarcinoma.

Learn more about the current study cohorts and eligibility information: https://tinyurl.com/6w46a4hm

World Lung Cancer Day brings attention to the people living with lung cancer and the continued need for progress in rese...
08/01/2026

World Lung Cancer Day brings attention to the people living with lung cancer and the continued need for progress in research and potential new treatment options.

For many patients, significant unmet needs remain. Our ongoing work with INBRX-106 includes research in Non-Small Cell Lung Cancer ( ) as part of our broader commitment to advancing oncology research.

Learn more about the INBRX-106 program: https://tinyurl.com/55whrp5m

World Head and Neck Cancer Day highlights the importance of awareness, research, and progress for people affected by hea...
07/27/2026

World Head and Neck Cancer Day highlights the importance of awareness, research, and progress for people affected by head and neck cancer.

This observance is also a reminder that significant unmet needs remain, underscoring the need for continued research and new treatment approaches.

Our ongoing research in head and neck cancer reflects a continued commitment to advancing work in this field.

Learn more about our research in head and neck cancer: https://tinyurl.com/55whrp5m

07/24/2026

For many patients with chondrosarcoma, treatment options have historically been limited, underscoring the importance of continued research in this rare cancer.

In this video, Dr. Breelyn Wilky shares her perspective on the challenges of treating chondrosarcoma and the need for ongoing progress in sarcoma research.

Learn more about our ongoing research in sarcoma with ozekibart (INBRX-109): https://tinyurl.com/y38wkwy6

Colorectal cancer remains one of the most common cancers in the United States, with more than 150,000 estimated new case...
07/23/2026

Colorectal cancer remains one of the most common cancers in the United States, with more than 150,000 estimated new cases expected in 2026.

This continued burden underscores the importance of ongoing research to deepen understanding of the disease and advance new treatment approaches.

Learn more about our ongoing research in colorectal cancer with ozekibart (INBRX-109): https://tinyurl.com/y38wkwy6

07/17/2026

This Sarcoma Awareness Month, Amanda’s story is a reminder of why continued research in chondrosarcoma remains so important.

As a chondrosarcoma survivor, she speaks to the limited treatment options many patients face and the importance of continued clinical research in rare cancers.

Learn more about our ongoing research in sarcoma with ozekibart (INBRX-109): https://tinyurl.com/y38wkwy6

July is Sarcoma Awareness Month, a time to recognize the individuals, families, caregivers, healthcare professionals, an...
07/06/2026

July is Sarcoma Awareness Month, a time to recognize the individuals, families, caregivers, healthcare professionals, and advocates dedicated to improving the lives of people affected by sarcoma.

Sarcomas are rare and complex cancers that can present unique challenges in diagnosis and treatment. Advancing research, increasing awareness, and fostering collaboration across the sarcoma community are essential to helping address ongoing unmet needs.

At Inhibrx, we are committed to advancing oncology research, including our work in conventional chondrosarcoma and Ewing sarcoma, with the goal of helping improve outcomes for people living with these rare cancers.

Learn more about our ongoing research in sarcoma: https://tinyurl.com/y38wkwy6

Patients with rare cancers often face limited treatment options and significant unmet needs, making continued research c...
06/25/2026

Patients with rare cancers often face limited treatment options and significant unmet needs, making continued research critically important.

At Inhibrx, we are focused on advancing research in conventional chondrosarcoma and Ewing sarcoma through our ozekibart (INBRX-109) program, alongside broader oncology research with our INBRX-106 program.

Every step forward in research brings us closer to expanding treatment possibilities for patients who need them most.

Learn more: https://tinyurl.com/catfc3pt

June is Cancer Immunotherapy Awareness Month, a time to recognize the importance of continued research in immunotherapy ...
06/17/2026

June is Cancer Immunotherapy Awareness Month, a time to recognize the importance of continued research in immunotherapy for patients facing cancer.

Learn more about how Inhibrx is contributing to oncology research through our investigational programs: https://tinyurl.com/catfc3pt

Address

Torrey Pines Science Park 11025 N Torrey Pines Road #200
La Jolla, CA
92037

Website

Alerts

Be the first to know and let us send you an email when Inhibrx Biosciences, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category